Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial

Overview of attention for article published in Lancet Neurology, December 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 6 public wall posts from 5 users.

In this population of patients with the parkinsonian variant of multiple system atrophy, treatment with rasagiline 1 mg per day…

Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled…

Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled…

http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2814%2970288-1/abstract www.thelancet.com

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 2 additional Facebook posts.